ElizabethJ.ShpallMD

PubMed

• Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms.
  Jayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, Guillin Tang, Tapan Kadia
  Haematologica. 2024-12-12
• Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis and Splanchnic Vein Thrombosis: A Case Series.
  Portia Smallbone, Mallika Sekhar, Samer A Srour, Jeremy L Ramdial, Crystal L Carmicheal Kusy
  American Journal of Hematology. 2024-12-09
• 1 citations
  A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete Remission.
  Zaid Abdel Rahman, Tamer Othman, Rima M Saliba, Yenny Alejandra Moreno Vanegas, Razan Mohty
  Transplantation and Cellular Therapy. 2024-12-01

Journal Articles

• The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients  
  Roy F Chemaly, Elizabeth Shpall, The Journal of Infectious Diseases
• Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell Therapy  
  Kris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature

Abstracts/Posters

• Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Combining CAR Engineering and CIS Checkpoint Deletion in NK Cells for the Treatment of B Cell Hematologic Malignancies
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS Patients
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Improved Outcomes for Patients Receiving High-Doses of IL-21 Ex Vivo Expanded NK Cells after Haploidentical Transplantation (haploSCT): Long-Term Follow-up of a Phase ...
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
  Elizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Assessment and Management of Cytokine Release Syndrome 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
• Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Manufacture of Clinical-Grade Universal Antigen Presenting Cells (UAPC) for the Ex Vivo Expansion and Activation of Natural Killer (NK) Cells 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018